Nasal Spray COVID Vaccine Shows Promise in Early Trial
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — New research points to the potential of a COVID-19 vaccine delivered through the nose. The phase 1 clinical trial showed that the product, administered nasally in two doses, delivered a significant immune response to multiple COVID variants. Called CoviLiv, the vaccine was testedContinue Reading